Zum Hauptinhalt springen
UB Hagen

Suchergebnisse

UB Katalog

Artikel & mehr
22 Treffer

Suchmaske

Suchtipp für den Bereich Artikel & mehr: Wörter werden automatisch mit UND verknüpft. Eine ODER-Verknüpfung erreicht man mit dem Zeichen "|", eine NICHT-Verknüpfung mit einem "-" (Minus) vor einem Wort. Anführungszeichen ermöglichen eine Phrasensuche.
Beispiele: (burg | schloss) -mittelalter, "berufliche bildung"

Das folgende Suchfeld wird hier nicht unterstützt: "Signatur / Strichcode".

Suchergebnisse einschränken oder erweitern

Aktive Suchfilter

Erscheinungszeitraum

Mehr Treffer

Weniger Treffer

Gefunden in

Art der Quelle

Schlagwort

Sprache

Geographischer Bezug

22 Treffer

Sortierung: 
  1. Detailansicht für Treffer 1 öffnen
    Carcinoembryonic antigen kinetics predict response to first-line treatment in metastatic colorectal cancer: Analysis from PRODIGE 9 trial.
    Salfati, D ; Huot, M ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 55 (2023-06-01), Heft 6, S. 791-798
    academicJournal
    Wie komme ich dran?
  2. Detailansicht für Treffer 2 öffnen
    Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trial.
    Merle, P ; Blanc, JF ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 55 (2023-04-01), Heft 4, S. 464-470
    academicJournal
    Wie komme ich dran?
  3. Detailansicht für Treffer 3 öffnen
    FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer.
    Randrian, V ; Pernot, S ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 54 (2022-07-01), Heft 7, S. 857-863
    academicJournal
    Wie komme ich dran?
  4. Detailansicht für Treffer 4 öffnen
    SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer.
    Boisteau, E ; François, E ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 54 (2022-06-01), Heft 6, S. 747-754
    academicJournal
    Wie komme ich dran?
  5. Detailansicht für Treffer 5 öffnen
    Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49.
    Pernot, S ; Pellerin, O ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 54 (2022-03-01), Heft 3, S. 324-330
    academicJournal
    Wie komme ich dran?
  6. Detailansicht für Treffer 6 öffnen
    Surveillance of colorectal cancers following curative-intent surgery: "Whatever the cost?"
    Lepage, C ; Bouché, O ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 54 (2022-03-01), Heft 3, S. 293-295
    editorialOpinion
    Wie komme ich dran?
  7. Detailansicht für Treffer 7 öffnen
    Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial.
    Gallois, C ; Emile, JF ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 53 (2021-10-01), Heft 10, S. 1254-1259
    academicJournal
    Wie komme ich dran?
  8. Detailansicht für Treffer 8 öffnen
    Impact of laparoscopy on oncological outcomes after colectomy for stage III colon cancer: A post-hoc multivariate analysis from PETACC8 European randomized clinical trial.
    Voron, T ; Karoui, M ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 53 (2021-08-01), Heft 8, S. 1034-1040
    academicJournal
    Wie komme ich dran?
  9. Detailansicht für Treffer 9 öffnen
    FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin.
    Hadoux, J ; Afchain, P ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 53 (2021-07-01), Heft 7, S. 824-829
    academicJournal
    Wie komme ich dran?
  10. Detailansicht für Treffer 10 öffnen
    What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort.
    Bacci, M ; Quero, L ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 53 (2021-06-01), Heft 6, S. 776-784
    academicJournal
    Wie komme ich dran?
  11. Detailansicht für Treffer 11 öffnen
    PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer.
    Evrard, C ; Louvet, C ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 53 (2021-04-01), Heft 4, S. 420-426
    academicJournal
    Wie komme ich dran?
  12. Detailansicht für Treffer 12 öffnen
    Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR).
    Tougeron, D ; Michel, P ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 53 (2021-03-01), Heft 3, S. 306-308
    academicJournal
    Wie komme ich dran?
  13. Detailansicht für Treffer 13 öffnen
    Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial.
    Taïeb, J ; André, T ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 53 (2021-03-01), Heft 3, S. 318-323
    academicJournal
    Wie komme ich dran?
  14. Detailansicht für Treffer 14 öffnen
    "Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial".
    Taïeb, J ; Benhaim, L ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 52 (2020-07-01), Heft 7, S. 730-733
    academicJournal
    Wie komme ich dran?
  15. Detailansicht für Treffer 15 öffnen
    COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).
    Di Fiore, F ; Bouché, O ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 52 (2020-06-01), Heft 6, S. 597-603
    academicJournal
    Wie komme ich dran?
  16. Detailansicht für Treffer 16 öffnen
    Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).
    de Mestier L ; Lepage, C ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 52 (2020-05-01), Heft 5, S. 473-492
    academicJournal
    Wie komme ich dran?
  17. Detailansicht für Treffer 17 öffnen
    Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, non-comparative phase II study.
    Randrian, V ; Adenis, A ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 52 (2020-03-01), Heft 3, S. 347-350
    academicJournal
    Wie komme ich dran?
  18. Detailansicht für Treffer 18 öffnen
    Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III study.
    Phelip, JM ; Edeline, J ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 51 (2019-02-01), Heft 2, S. 318-320
    academicJournal
    Wie komme ich dran?
  19. Detailansicht für Treffer 19 öffnen
    Patterns of care and outcomes in oesophageal cancer.
    Jooste, V ; Manfredi, S ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 50 (2018-11-01), Heft 11, S. 1238-1243
    academicJournal
    Wie komme ich dran?
  20. Detailansicht für Treffer 20 öffnen
    Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK).
    Michel, P ; Boige, V ; et al.
    In: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Jg. 50 (2018-03-01), Heft 3, S. 305-307
    academicJournal
    Wie komme ich dran?
xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -